Corporate Science calls for papers / meetings & conferences

Call for Abstracts: Molecular Pharming - Recent Progress in Manufacturing Medicines in Plants

Friday, 21 September 2012 09:00 - 17:00 London, United Kingdom

Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.

This meeting will review the progress of the field, highlight major technological advances and scan the horizon for future developments.

The Deadline for abstract submissions for oral presentation is June 10th 2012

Abstracts for poster presentation only can be submitted up to two weeks before the event

Please note that there will be a best poster prize.

Contact Details

Email: enquiries@euroscicon.com

Web: www.euroscicon.com

For all accommodation and travel enquiries please contact accommodationandtravel@euroscicon.com

Call for Abstracts: 3rd Annual International Conference on Advances in Biotechnology (BioTech 2013)

18 - 19 March 2013 Singapore

Paper Submission (Full Paper) Deadline 28 September 2012

Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. The concept encompasses a wide range of procedures for modifying living organisms according to human purposes - going back to domestication of animals, cultivation of plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization.

This multi-disciplinary conference aims to provide a challenging forum and vibrant opportunity for researchers and industry practitioners to share their original research results and practical development experiences on specific new challenges and emerging issues.

Topics of interest include, but are not limited to:

Pharmaceutical / Medicine

• Structural Biology
• Proteomics
• Cell Cycle and Oncology
• Medical Microbiology
• Diagnostic Pathology
• Clinical Chemistry
• Haematology
• Diagnostic Imaging
• Medical Imaging and Methods
• Sonography
• Molecular and Cell Biology
• Biochemistry
• Immunology
• Genetics
• Neurobiology
• Drug production
• Pharmacogenomics
• Gene therapy
• Factors for transcribing DNA into RNA
• Monoclonol antibodies
• Pathogenesis of Human Diseases
• Presymptomatic testing

Food and Agriculture

• Genetic engineering
• Genomics
• Tissue culture
• Cell fusion
• Molecular biology
• Enzymology
• Fermentation processes
• Instrumentation and diagnostic methods
• Food processing
• Biofertilizer
• Waste Technology
• Environment Control
• Pest and diseases resistant crop
• High value addictives and chemical products
• Immunological techniques
• Signal transduction
• Conjugation
• Classical mutagenesis
• Conjugation process
• Hybridisation

Best Paper Award

A number of best papers will be selected and given awards at the conference. These papers will also be considered for publication in GSTF and other international refereed Journals.

In order to qualify for the award, at least one of the authors will need to present at the conference.

CONFERENCE SECRETARIAT 

Global Science & Technology Forum (GSTF)
10 Anson Road, International Plaza,
Singapore 079903
DID : +65 6327 0166
Fax : +65 6327 0162 

For Conference Information info@advbiotech.org 
For Registration, Accommodation or Visa Assistance secretariat@advbiotech.org  

Call for Abstracts: SLAS2013, the 2nd Annual Society for Laboratory Automation & Screening Conference and Exhibition

January 12-16, 2013 Orlando, Florida

The Society for Laboratory Automation and Screening (SLAS) invites research scientists, engineers, academics and business leaders to submit abstracts for presentation at SLAS2013, the 2nd Annual SLAS Conference and Exhibition. Showcase your innovation on a global stage by participating in this leading scientific program rich with content for those within the laboratory science and technology community. Areas of focus include: drug discovery and development, informatics, clinical diagnostics, food and agricultural sciences, forensics and security sciences, petrochemicals and energy, and consumer products.

Abstract submissions from academia, government and industry are welcome. Contributions from graduate students, post-doctoral associates and junior faculty are encouraged.

Important Deadlines

Podium Abstract Submissions Due: Monday, July 30, 2012

Poster Abstract Submissions Due: Friday, October 26, 2012

Call for Papers: IEEE-EMBS Micro- and Nanoengineering in Medicine Conference (MNMC 2012)

Translating Technology from the Bench to the Bedside

December 3-7, 2012 The Westin Maui Resort and Spa, Ka’anapali, Hawaii

Call for Papers Opened: July 1, 2012

Call for Papers Site Closed: August 1, 2012

Notification of Acceptance: September 1, 2012

Various biomedical grand challenges facing our society and the world can be addressed by interfacing biology and medicine with micro- and nanoscale technologies. These technologies hold great potential to impact early diagnosis, therapeutics, and management of disease. IEEE EMBS is sponsoring the first Conference on Micro- and Nanoengineering in Medicine to foster interaction between scientists, engineers and medical researchers in the context of real-world medical needs and issues. The Conference will promote vigorous and open dialogue towards the development of cutting edge technologies for faster, more quantitative, and less expensive biomedical solutions using advances in micro and nanotechnology.

Keywords for Papers

Global health
Microfluidics
Nanotechnology
Microfabrication
Stem cells
Regenerative medicine
Tissue engineering
Diagnostics
Bionanotechnology
BioMEMS
Point-of-care
Nanomedicine
Lab-on-Chip

Call for Papers: 3rd AMA-IEEE Medical Technology Conference: Translational Engineering in Health & Medicine: the Intersection of the Lab, the Clinic and the Community

Abstract & Paper deadline: 10 September 2012

The American Medical Association (AMA) and the IEEE Engineering in Medicine and Biology (EMB) Society are pleased to announce the 3rd AMA-IEEE Medical Technology Conference: Translational Engineering in Health & Medicine: the intersection of the lab, the clinic and the community in Houston, TX, on 7th-9th November 2012 at the Methodist Hospital Research Institute in the Texas Medical Center.

This conference is devoted to the exploration of the intersection of engineering, medicine, and health. Emphasis will be placed on novel innovations that have a foreseeable impact on human health and disease. Specific areas of interest include Imaging; Nano Medicine; Data Mining and the Use of Large Datasets; Remote Sensing; Networks & Communication; Applied Metabolomics; Aerospace and Harsh Environments; and Global Health.

We invite participation by physicians, nurses and other healthcare professionals, engineers, innovators, entrepreneurs, industrial leaders, government agencies and policy makers. The conference will be inaugurated by a keynote lecture and evening reception on Wednesday, 7th November. The following two days will feature plenary, break-out sessions and poster presentations focusing on Translational Engineering in Health & Medicine. Authors interested in submitting manuscripts can either submit a 1 page abstract or a 4 page paper.

Accepted papers may be considered for publication in IEEE PULSE or The IEEE Journal on Translational Engineering in Health & Medicine (to be launched in 2013).

Call for Abstracts: Polymer Chemistry Conference 2012

Polymers: From Biomedical Applications to Energy

Monday November 12 2012 - Friday November 16 2012 Xcaret, Mexico

Talk abstract deadline: Tuesday June 26 2012
Poster abstract deadline: Wednesday September 12 2012

The continued application of synthetic chemistry to the development of new polymer-based materials has given polymer chemistry a critical role in the development of new materials across a broad range of applications that impact our lives, most recently in biomedical and energy-related areas. Synthetic methodologies that allow the shaping of polymeric materials to function as biomaterials in applications including tissue engineering, imaging, and the targeted delivery of drugs and biological materials will be presented. We will showcase creative designs and synthetic strategies for these multifunctional polymeric systems and composite materials. The multifaceted properties of polymers allow for the increasing advancement of polymers in energy-related applications. The optimization of polymer-based organic photovoltaic and hybrid materials for harvesting and storing solar energy, as well as the development of new semiconducting polymers will be topics of particular interest. The unique site and forum will give the attendees many opportunities to exchange ideas, discuss research challenges and forge new collaborations. The total number of attendees will be kept to a maximum of 100 to facilitate such interactions. The themes in 2012 will include: - Synthesis of Biomaterials - Applications of Nanomaterials in Medicine - Self assembly - Theranostics - Polymer Surfaces - Polymers for Imaging and Devices - Polymers and Energy

Contact us
For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').

For queries about scientific content, presentations, posters, etc. please email info~at~zingconferences.com (replace '~at~' with '@').
 

Call for Abstracts: Peptide Chemistry Conference 2012

Friday November 2 2012 - Tuesday November 6 2012 Xcaret, Mexico

The interest of pharmaceutical companies for peptides is increasing enormously in the last decade. There are several reasons for that. In first place, the number of the so-called small molecules accepted for the corresponding agencies are declining. In this sense, pharmaceutical are looking more to biological based drugs. Furthermore, the advances in fields of formulation, drug delivery technology and chemical modifications, have rekindled the interest in peptides as APIs.

This would not be possible without the concurrence of strong peptide chemistry. The development of new resins for the solid-phase methodology, coupling reagents, orthogonal protecting groups, and synthetic strategies are being allowed the rapid and efficient synthesis of small and large peptides for research and, then, the multi-ton preparation of the API based peptides.

This Zing conference will be totally devoted into the latest developments in peptide chemistry. In addition to the parameters outlined above, the following topics will be discussed:

Synthesis of building blocks
use of microwave and other technologies
syntheses of foldamers, peptide conjugates, and peptides for nanotechnologies
preparation of peptide libraries
chemical ligation for protein synthesis
syntheses of complex cyclic peptide of natural origin and peptide mimetics
industrial synthesis of peptides

Attendees from the academia and the industry as well Ph.D. students and post-doctoral fellows will fulfill an unique atmosphere around the peptide world.

Abstract submission Talk abstract deadline: Monday June 25 2012
Poster abstract deadline: Sunday September 2 2012

Contact us
For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').

For queries about scientific content, presentations, posters, etc. please email info~at~zingconferences.com (replace '~at~' with '@').

Call for Papers: Nanosafe 2012

After the success of Nanosafe 2008 and Nanosafe 2010, the next edition Nanosafe 2012 will be held from 13th to 15th November 2012 in Minatec, Grenoble, France .

Topics

Exposure assessment
Detection and identification
Toxicology
Environmental interactions
Nanomaterials release
Protection technology
Industrial production
Life Cycle Analysis
Ethics and societal issues
Commercial equipements
Risk management for OHS experts

Programme
The three-day programme for this conference will comprise:

-- Invited plenary lectures

G. Oberdörster (U. ROCHESTER), D. Pui (U. MINNESOTA), D. Brouwer (TNO), T. Nhuyen (NIST), F. Schuster (CEA), B. Nowack (EMPA), R. Muir (NANEUM). D. Bernard (ARKEMA), J. Rose (CEREGE), C. Engeman (UCSB) A. Grobe (U. STUTTGART). A. Grinbaum (CEA), F. Roure (FRENCH MINISTRY FOR ECONOMY, FINANCE AND INDUSTRY), A. Kishimoto (AIST, RISS), C. EMOND (U. MONTREAL), L. Golanski (CEA), O. Witschger (INRS), E. Drais (INRS).

-- Selected oral contributions

- Posters sessions

-- Panel discussions: Governance/ Toxicology/ The opinion of the civil society regarding nanomaterials

-- Exhibition of equipments related to safe production and use of nanomaterials

-- Satellite meetings: TITNT, TRIMATEC, NANOHOUSE

Papers will be presented in oral and poster sessions.

All accepted abstracts will be submitted online and published in a "Book of Abstract".

Full paper will be published after reviewing in the Journal of Physics: Conference Series.

Presentations will be available on the conference website

Deadline for abstracts: JULY 30, 2012

Call for Abstracts:12th International Symposium on Biosafety of Genetically Modified Organisms (ISBGMO12)

Abstract submission deadline: 25th May 2012

17-20 September 2012 St Louis, Missouri

The ISBGMO is a unique opportunity for scientists from across the globe to share experiences and engage in open and meaningful dialogue about biosafety.

Participants include scientists involved in biosafety research and policy, including regulatory authorities, technology developers, academics, non-government organizations, and other credible stakeholders.

The discussion at this ISBGMO12 will be focused on a theme: CONSIDERING BIOSAFETY IN THE APPLICATION OF BIOTECHNOLOGY TO MEET THE CHANGING NEEDS OF AGRICULTURE, HEALTH, AND THE ENVIRONMENT.

Under this theme, presentations and posters in the sessions, mini-symposia, and workshops will potentially address such timely topics, as they relate to biosafety:

New approaches in genetic engineering
Genetically engineered animals/insects
Biotechnology and climate change
Biotechnology and biofuels/energy
Biotechnology for developing countries
Transferring data for risk assessment across environments
Genetically engineered crops and agricultural sustainability
Post-market monitoring
Defining protection goals for risk assessment
Defining the receiving environment
Understanding environmental fate
Key discussions under the Cartagena Protocol on Biosafety
Effective capacity building for biotechnology regulation
And others...

The ISBGMO is a bienniel international meeting organized by the International Society for Biosafety Research (ISBR), a society whose membership is composed of individuals with an interest in risk assessment and research related to the environmental risks associated with genetically modified organisms (http://www.isbr.info/).

The ISBGMOs have been offered on a biennial basis since 1990, at various locations throughout the world, including most recently in Argentina (2010), New Zealand (2008), South Korea (2006), France (2004), China(2002), Canada (2000). The 2012 symposium in St. Louis will be the first time it has been offered in the US since it was held in Monterey, CA in 1994.

The Donald Danforth Plant Science Center in St. Louis, whose mission and goals are closely tied to the theme of ISBGMO12, is the local host for this symposium.

For all queries regarding your submitted abstract and program queries please contact:

Jun You
Publishing Content Coordinator
Email: j.you@elsevier.com